LOR anticorps (AA 58-107)
-
- Antigène Voir toutes LOR Anticorps
- LOR (Loricrin (LOR))
-
Épitope
- AA 58-107
- Reactivité
- Veuillez nous consulter SVP
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp LOR est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Specificité
- Human LOR / Loricrin
- Homologie
- Percent identity by BLAST analysis: Human (100%) Bovine (92%) Mouse (85%) Rat (81%).
- Purification
- Protein A purified
- Immunogène
-
Synthetic peptide located between aa58-107 of human LOR (P23490, NP_000418). Percent identity by BLAST analysis: Human, Gorilla (100%), Bovine (92%), Mouse (85%), Rat (81%).
Type of Immunogen: Synthetic peptide - Isotype
- IgG
- Top Product
- Discover our top product LOR Anticorps primaire
-
-
- Indications d'application
- Approved: IHC, IHC-P, WB (5 μg/mL)
- Commentaires
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
- Concentration
- Lot specific
- Buffer
- Lyophilized from PBS with 2 % sucrose
- Conseil sur la manipulation
- Avoid repeat freeze-thaw cycles.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- Antigène
- LOR (Loricrin (LOR))
- Autre désignation
- Loricrin (LOR Produits)
- Synonymes
- anticorps AI036317, anticorps S77319, anticorps RGD1559993, anticorps LOR, anticorps loricrin, anticorps Loricrin, anticorps LOR, anticorps Lor, anticorps TVAG_146950, anticorps TVAG_228830, anticorps TVAG_228920, anticorps TVAG_238290, anticorps TVAG_035050, anticorps TVAG_070680, anticorps Bm1_52290, anticorps LOC100281109, anticorps LOC100281170
- Classe de substances
- Chemical
- Sujet
-
Name/Gene ID: LOR
Synonyms: LOR, Loricrin, LRN - ID gène
- 4014
- NCBI Accession
- NP_000418
-